Nymox Pharmaceutical Corporation NYMX
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 18.25M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- 0.00
- Beta
- 0.65
- Short ratio
- 59.73
- Inst. own
- 1.12%
- Dividend
- 0.00
- Ex-div date
- Earnings
- May 12, 2023
- 50-d avg
- 0.385079
- 200-d avg
- 0.385119
- 1y target
- 10.25
MAX chart
Chart tools
Chart is warming up
The all-time price history for NYMX has not been loaded yet. Try again in a moment.
Altman Z-Score
-1079.34 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -4.4×
P/S 0.0×
P/B -60.0×
P/FCF -5.6×
EV/EBITDA -4.4×
EV/Sales 0.0×
FCF Yield -18.0%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE 1363.3%
ROIC 2151.1%
ROA -404.4%
Revenue 0.0%
Operating Income 46.8%
EPS (diluted) 51.0%
Free Cash Flow 47.0%
Current Ratio 0.7×
Quick Ratio 0.7×
Debt / Equity -0.4×
Net Debt / EBITDA 0.2×
Interest Coverage -155×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2022-12-31